middle.news
Cleo Diagnostics Completes Trial Recruitment and Advances FDA Submission Prep
9:56am on Wednesday 29th of April, 2026 AEST
•
Healthcare
Read Story
Cleo Diagnostics Completes Trial Recruitment and Advances FDA Submission Prep
9:56am on Wednesday 29th of April, 2026 AEST
Key Points
Pivotal U.S. trial surpasses 500 sample target
Bio-Techne’s Ella™ platform chosen for commercial test
Biomarker panel expanded to eight markers
Manufacturing program with Bio-Techne underway
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Cleo Diagnostics (ASX:COV)
OPEN ARTICLE